Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat‐and‐extend compared with pro re nata in eyes with neovascular age‐related macular degeneration

PURPOSE: To evaluate treatment outcome at 12 months in eyes with neovascular age‐related macular degeneration (nAMD) treated with antivascular endothelial growth factor (anti‐VEGF) injections according to either pro re nata (PRN)‐ or treat‐and‐extend (TE)‐regimen in one clinical setting in Sweden. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurell, Sandra, Sjövall, Kersti, Paul, Anna, Morén, Åsa, Granstam, Elisabet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767032/
https://www.ncbi.nlm.nih.gov/pubmed/30511374
http://dx.doi.org/10.1111/aos.13989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767032/
https://www.ncbi.nlm.nih.gov/pubmed/30511374
http://dx.doi.org/10.1111/aos.13989

Ejemplares similares